Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism

Metabolic Brain Disease

Volumn 23, Issue 3, 2008, Pages 315-324

  Heikkilä, Outi ^a,b   Lundbom, Nina ^a   Timonen, Marjut ^a   Groop, Per Henrik ^a,b   Heikkinen, Sami ^a   Mäkimattila, Sari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Brain metabolism; Creatine; Glucose; Metabolic syndrome; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUCOSE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN LEVEL; BRAIN METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISORDERS OF CARBOHYDRATE METABOLISM; ENERGY METABOLISM; FAMILY HISTORY; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; RISK FACTOR; THALAMUS; WHITE MATTER;

ADULT; ANTHROPOMETRY; ASPARTIC ACID; BLOOD GLUCOSE; CHOLINE; CREATINE; DIABETES MELLITUS, TYPE 2; HUMANS; INOSITOL; INSULIN; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC SYNDROME X; RISK FACTORS; THALAMUS;

EID: 50049125602     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-008-9094-5     Document Type: Article

References (30)

1. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480
2. Arenillas JF, Moro MA, Davalos A (2007) The metabolic syndrome and stroke: potential treatment approaches. Stroke 38:2196-2203
3. Baslow MH (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941-953
4. Brosnan JT, Brosnan ME (2007) Creatine: endogenous metabolite, dietary, and therapeutic supplement. Annu Rev Nutr 27:241-261
5. Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A (2002) Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. J Am Geriatr Soc 50:1707-1710
6. de Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL (2001) Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab 21:483-492
7. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J, Breteler MM (2002) Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125:765-772
8. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Garner J, Jack L, Carmelli D (1999) Predictors of brain morphology for the men of the NHLBI twin study. Stroke 30:529-536
9. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, Sundgren PC (2005) Magnetic resonance spectroscopy. J Neuro-ophthalmol 25:217-226
10. Heilig CW, Stromski ME, Blumenfeld JD, Lee JP, Gullans SR (1989) Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol 257:F1108-F1116
11. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW (2006) Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37:466-470
12. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Salonen JT (2005) C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J 26:1783-1789
13. Maheshwari SR, Fatterpekar GM, Castillo M, Mukherji SK (2000) Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 21:434-451
14. Mäkimattila S, Malmberg-Ceder K, Häkkinen AM, Vuori K, Salonen O, Summanen P, Yki-Järvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO (2004) Brain metabolic alterations in patients with type 1 diabetes- hyperglycemia-induced injury. J Cereb Blood Flow Metab 24:1393-1399
15. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, Kappelle LJ, on behalf of the Utrecht Diabetic Encephalopathy Study Group (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50:2388-2397
16. Mason GF, Pan JW, Chu WJ, Newcomer BR, Zhang Y, Orr R, Hetherington HP (1999) Measurement of the tricarboxylic acid cycle rate in human grey and white matter in vivo by 1H-[13C] magnetic resonance spectroscopy at 4.1T. J Cereb Blood Flow Metab 19:1179-1188
17. Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201-2207
18. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89-131
19. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA (2006) Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 166:106-111
20. Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, Hosova K, Terasaki T (2002) The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 22:1327-1335
21. Pouwels PJ, Brockmann K, Kruse B, Wilken B, Wick M, Hanefeld F, Frahm J (1999) Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 46:474-485
22. Prichard JW, Alger JR, Behar KL, Petroff OA, Shulman RG (1983) Cerebral metabolic studies in vivo by 31P NMR. Proc Natl Acad Sci U S A 80:2748-2751
23. Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54-84
24. Seaquist ER, Damberg GS, Tkac I, Gruetter R (2001) The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 50:2203-2209
25. Sinha S, Misra A, Kumar V, Jagannathan NR, Bal CS, Pandey RM, Singhania R, Deepak (2004) Proton magnetic resonance spectroscopy and single photon emission computed tomography study of the brain in asymptomatic young hyperlipidaemic Asian Indians in North India show early abnormalities. Clin Endocrinol (Oxf) 61:182-189
26. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27:2676-2681
27. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2005) C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112:900-905
28. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S (2007) Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 4:111-116
29. Yudkin JS (1999) Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diabetes Care 22(Suppl 3):C25-C30
30. Virtanen KA, Hirvonen J, Bucci M, Honka M, Nesterov S, Iozzo P, Rinne OJ, Nuutila P (2007) Insulin-stimulated brain glucose uptake is enhanced in subjects with impaired glucose tolerance (IGT). Diabetologia 50(Suppl 1):A0017 (Abstract)